Title:
ORAL SOLID PREPARATION
Document Type and Number:
WIPO Patent Application WO/2023/149546
Kind Code:
A1
Abstract:
The present invention addresses the problem of providing an oral solid preparation having rapid dissolution even if the content of linzagolix or a pharmacologically acceptable salt thereof in the oral solid preparation differs over a wide range. The present invention relates to an oral solid preparation containing: linzagolix or a pharmacologically acceptable salt thereof; crystalline cellulose; low-substituted hydroxypropyl cellulose; and one or more disintegrating agents selected from the group consisting of carmellose sodium, carmellose calcium, and croscarmellose sodium.
Inventors:
IMAMURA YUSUKE (JP)
MIMURA KAZUKI (JP)
MIMURA KAZUKI (JP)
Application Number:
PCT/JP2023/003575
Publication Date:
August 10, 2023
Filing Date:
February 03, 2023
Export Citation:
Assignee:
KISSEI PHARMACEUTICAL (JP)
International Classes:
A61K31/519; A61K9/20; A61K9/30; A61K9/32; A61K9/36; A61K47/26; A61K47/38; A61P5/24
Domestic Patent References:
| WO2018030317A1 | 2018-02-15 | |||
| WO2011099507A1 | 2011-08-18 | |||
| WO2022004871A1 | 2022-01-06 | |||
| WO2009101940A1 | 2009-08-20 |
Attorney, Agent or Firm:
YANAGI, Nobuko et al. (JP)
Download PDF:
Previous Patent: COMMUNICATION DEVICE AND COMMUNICATION SYSTEM
Next Patent: POLYAMIDE RESIN COMPOSITION AND FILM THEREOF
Next Patent: POLYAMIDE RESIN COMPOSITION AND FILM THEREOF